Ro's New AI Agent Aims to Be Your Healthcare 'Quarterback' — CEO Reveals Bigger Plan

Ro, the direct-to-consumer healthcare company valued at $6.6 billion, is rolling out an AI agent designed to coordinate more of a patient's care journey. CEO Zachariah Reitano demonstrated the new tool, which can help users manage medications, schedule follow-ups, and navigate insurance questions. The move signals Ro's ambition to become a central hub—a 'quarterback'—for healthcare, moving beyond its roots in telehealth and prescription delivery. The AI agent builds on Ro's existing platform, which already serves millions of patients across weight management, sexual health, and dermatology. By integrating conversational AI, Ro aims to reduce friction in care coordination, a persistent pain point in the fragmented U.S. healthcare system. Reitano emphasized that the agent is not meant to replace doctors but to handle administrative and routine tasks, freeing clinicians for higher-value interactions. Ro faces stiff competition from other digital health players like Amazon Clinic and Hims & Hers, which are also investing in AI-driven services. However, Ro's vertically integrated model—combining telehealth, pharmacy, and now AI—could give it an edge in controlling the patient experience end-to-end. The company has already expanded into in-home care and diagnostics, and the AI agent is a logical next step in that strategy. If successful, Ro's AI agent could reshape how millions of Americans manage their health, making care more proactive and personalized. The challenge will be earning trust in an era of AI skepticism. But with healthcare costs rising and access still uneven, tools that simplify the journey may find a ready audience.